Efficacy and Safety Analysis of Modified HSG for Infertile Patients

Abstract

To test the efficacy and safety of modified hysterosalpingography (HSG) for infertile patients.Altogether 110 infertile cases from March 2018 to July 2020 were grouped into the observation group (OG, 58 cases) and the control group (CG, 52 cases) according to different therapies. The OG was treated with modified HSG, while the CG was treated with conventional HSG. The tubal patency after treatment, sex hormone levels before and after therapy [including luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2)], changes in uterine volume and endometrial thickness before and after therapy were tested and compared between the CG and the OG. The individuals were followed up for one year, and the pregnancy success rate was recorded. Finally, the adverse reactions of the CG and the OG after treatment were recorded and compared.After treatment, the sex hormone level, tubal patency, uterine volume and endometrial thickness of the CG and the OG were markedly elevated, but the improvement of the OG was more obvious than that of the CG. Follow-up analysis revealed that the pregnancy success rate of theOG was markedly higher than that of theCG, and the incidence of adverse reactions in OG was markedly lower than that in CG.The modified HSG can effectively improve the pregnancy situation of patients and has higher safety compared with the traditional HSG, so it is worth popularizing in clinic.